My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1030

    1.

    Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mallée C, de Beus WM, de Sonnaville PB, Ewals JA, Breedveld FC, Dijkmans BA.

    Ann Intern Med. 2007 Mar 20;146(6):406-15.PMID: 17371885 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

    Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA; FARR study group.

    Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-77-82.PMID: 17083767 [PubMed - indexed for MEDLINE]Related articles

    3.

    Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

    Arthritis Rheum. 2005 Nov;52(11):3381-90.PMID: 16258899 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.

    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

    Arthritis Rheum. 2008 Feb;58(2 Suppl):S126-35.PMID: 18240203 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.

    Allaart CF, Breedveld FC, Dijkmans BA.

    J Rheumatol Suppl. 2007 Nov;80:25-33.PMID: 17985420 [PubMed - indexed for MEDLINE]Related articles

    6.

    Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

    van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

    Ann Rheum Dis. 2009 Jun;68(6):914-21. Epub 2008 Jul 28.PMID: 18662933 [PubMed - indexed for MEDLINE]Related articles

    7.

    COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.

    Landewé RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BA, Jacobs P, Boonen A, van der Heijde DM, van der Linden S.

    Arthritis Rheum. 2002 Feb;46(2):347-56.PMID: 11840436 [PubMed - indexed for MEDLINE]Related articles

    8.

    Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial).

    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, Kerstens PJ, Grillet BA, de Jager MH, Han KH, Speyer I, van der Lubbe PA, Seys PE, Breedveld FC, Dijkmans BA.

    Ann Rheum Dis. 2007 Sep;66(9):1227-32. Epub 2007 Apr 3.PMID: 17405834 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.

    van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW.

    Ann Intern Med. 2002 Jan 1;136(1):1-12.PMID: 11777359 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.

    Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P.

    Arthritis Rheum. 2005 Jan;52(1):27-35.PMID: 15641102 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

    de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.

    Arthritis Rheum. 2008 May;58(5):1293-8.PMID: 18438829 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.

    Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skjødt H, Lauridsen UB, Ellingsen T, Hansen GV, Lindegaard H, Vestergaard A, Jurik AG, Østergaard M, Hørslev-Petersen K; CIMESTRA study group.

    Ann Rheum Dis. 2008 Jun;67(6):815-22. Epub 2007 Sep 18.PMID: 17878209 [PubMed - indexed for MEDLINE]Related articles

    13.

    Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S.

    Lancet. 1997 Aug 2;350(9074):309-18. Erratum in: Lancet 1998 Jan 17;351(9097):220. PMID: 9251634 [PubMed - indexed for MEDLINE]Related articles

    14.

    Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.

    Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Blåfield H, Puolakka K, Möttönen T; FIN-RACo Trial Group.

    Arthritis Rheum. 2004 Jul;50(7):2072-81.PMID: 15248204 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M; TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.

    Lancet. 2004 Feb 28;363(9410):675-81.PMID: 15001324 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

    van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF.

    Ann Rheum Dis. 2009 Jul;68(7):1153-8. Epub 2008 Oct 17.PMID: 18930988 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.

    Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C.

    Lancet. 1999 May 8;353(9164):1568-73.PMID: 10334255 [PubMed - indexed for MEDLINE]Related articles

    18.

    Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.

    Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I.

    Arthritis Rheum. 2005 Nov;52(11):3360-70.PMID: 16255010 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

    St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, Keystone E, Schiff M, Kalden JR, Wang B, Dewoody K, Weiss R, Baker D; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group.

    Arthritis Rheum. 2004 Nov;50(11):3432-43.PMID: 15529377 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

    Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT.

    Arthritis Rheum. 2006 Jan;54(1):26-37.PMID: 16385520 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity